# OnCo record paper-nct04619004-j-clin-oncol-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct04619004-j-clin-oncol-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct04619004-j-clin-oncol-2023" ;
  schema:name "HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy"@en ;
  schema:description "Published report from the HERTHENA-Lung01 trial registered as NCT04619004, in Journal of Clinical Oncology (2023), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct04619004-j-clin-oncol-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.23.01476>, <https://pubmed.ncbi.nlm.nih.gov/37689979/>, <https://europepmc.org/article/MED/37689979>, <https://clinicaltrials.gov/study/NCT04619004> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.23.01476> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Yu HA, Goto Y, Hayashi H, et al." ;
  onco:trials <https://onco.cc/trials/nct04619004/> ;
  onco:journals <https://onco.cc/journals/jco/> .